Rp Medhelix Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.97 M
as on 24-10-2024
- Revenue 46.02%
(FY 2023)
- Profit 41.88%
(FY 2023)
- Ebitda 160.31%
(FY 2023)
- Net Worth -45.63%
(FY 2023)
- Total Assets -12.75%
(FY 2023)
About Rp Medhelix Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.97 M.
Raghunath Unni, Sreekala Rohit, and Parvathy Ghosh serve as directors at the Company.
- CIN/LLPIN
U85195KL2015PTC038313
- Company No.
038313
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rp Medhelix Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreekala Rohit  | Managing Director | 20-Apr-2015 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghunath Unni | Director | 12-Dec-2019 | Current |
| Parvathy Ghosh | Director | 20-Apr-2015 | Current |
Financial Performance of Rp Medhelix Diagnostics.
Rp Medhelix Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.02% increase. The company also saw a substantial improvement in profitability, with a 41.88% increase in profit. The company's net worth observed a substantial decline by a decrease of 45.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rp Medhelix Diagnostics?
In 2023, Rp Medhelix Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 06 Dec 2021 | ₹0.15 M | Open |
Hdfc Bank Limited Creation Date: 24 Sep 2021 | ₹4.53 M | Open |
Canara Bank Creation Date: 30 Sep 2015 | ₹1.30 M | Open |
How Many Employees Work at Rp Medhelix Diagnostics?
Unlock and access historical data on people associated with Rp Medhelix Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rp Medhelix Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rp Medhelix Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
